2nd Annual IRDD Summit 2020

DESCRIPTION

On 28 & 29 May 2020, New York (USA) will host the 2nd Annual IRDD Summit 2020 (Inhalation & Respiratory Drug Delivery 2020 conference). This year’s event is designed for senior industry experts that will showcase new trends in aerosol science and the future directions of inhalation drug delivery research. Further discussion focusses on the regulatory pathways for inhaled therapies and challenges of bringing respiratory products to market. The agenda also features key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy.

Over 100+ delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will be joining the Inhalation & Respiratory Drug Delivery 2020

A recent report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found America’s biopharmaceutical companies are developing about 130 new medicines for the millions of patients affected by respiratory diseases: chronic obstructive pulmonary disease (COPD), cystic fibrosis, pneumonia, and asthma. These medicines represent critical advancements in respiratory care and improving quality of life. In addition to the drugs, devices delivering those products are being designed to improve the quality of life for an aging population, children, and those who tend not to comply to dosing regimens because they don’t know how to use the device. The global respiratory care devices market is expected to exceed more than $24 billion by 2022,2 and could exceed $33 billion by 2023.

Over 20+ presentations and case studies focused on the key issues in inhalation and respiratory drug delivery.

The 2nd Annual IRDD Summit 2020 will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis. The event highlights some of the innovators and innovations in the respiratory sector, addresses the importance of end users in the device development process, and presents recent advancements in improving patient adherence.


KEY PRACTICAL LEARNING POINTS

  • Novel technologies for pulmonary & nasal delivery
  • Modern respiratory medicines
  • Innovative development of inhalation devices
  • Digital health combination products
  • Analytical tools for inhaled medicines
  • Challenges of bringing inhalation and respiratory drug delivery products to market
  • Regulatory updates in the global respiratory market
  • The challenges of developing inhalation devices
  • Alternative therapeutic fields
  • Innovation in nebulised therapy
  • Triple inhaler therapy in COPD
  • Inhaled drugs through functional respiratory imaging (FRI) and artificial intelligence (AI)
  • Dry-powder inhalers (DPIs) and Metered-dose inhalers (MDIs)
  • New analytical insights into dry powder formulations for inhalation
  • Routes to controlling aerosol response
  • Characterizing aerosol dynamics
  • Model validation
  • Future directions in inhalation and respiratory drug delivery research
  • Regulatory pathways for inhaled therapies
  • Strategies for Managing the Impact of Brexit
  • Challenges of developing a generic inhaled product
  • Explore opportunities with smart and digital inhalers

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of:

  • Respiratory Drug Development
  • Generics & Respiratory
  • Inhalation Drug Delivery Technologies
  • Device Development and Engineering
  • Respiratory Pharmacology
  • Medical Devices & Injectors
  • Inhalation Device Development
  • Inhaled Formulation Science
  • Inhalation Product Development
  • Respiratory Regulations
  • Generics & Respiratory
  • Inhalation Process Development
  • Respiratory Medicine
  • Inhalation Drug Delivery
  • E-Health
  • Inhaled Dosage Forms
  • Outsourcing
  • Process Development
  • Respiratory Pharmacology
  • Device Engineering
  • Drug Delivery Innovation
  • Inhalation Devices
  • Metered Dose Inhaler Development
  • Medical Marketing
  • Respiratory R&D
  • Particle Characterisation
  • Business Development
  • New Delivery Technologies
  • Connective Health
  • Respiratory Regulations
  • Pulmonary Disease
  • Inhalation
  • Scientific Research

Chief Executive Officer at MannKind Corporation
Inhaled Biopharmaceutical Development Scientist at Hovione
CEO at FLUIDDA
Founder and CEO at Quench Medical
Research Professor at INSERM, Research Centre for Respiratory Diseases
Global Lead of Inhalation Science and Engineering at Covance
Director, Scientific Affairs at Celerion
Head of Global CMC Experts at Boehringer Ingelheim Pharma GmbH & Co. KG
Director Inhalation Technology at Harro Höfliger
Professor of Physiology at the University of Oxford
Founder and CEO at Proveris Scientific
Scientific Business Development Manager at ACG
Professor of Pharmaceutics at Virginia Commonwealth University School of Pharmacy
Director, Scientific Affairs at Eurofins BioPharma Product Testing
Professor of patient centric drug design and manufacturing at the Graz University of Technology, Austria
University Distinguished Professor at the Texas Tech University Health Sciences Center (TTUHSC)
Academic Package
Early Bird

2-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Event Certificate

Poster Presentation

500
Industry Package
Early Bird Rate

2-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Gala Dinner

Unique 1-on-1 meetings

1,495
Premium Package
Early Bird

2-Days Summit

Full-Access to all Sessions

Coffee Breaks/Lunches

Gala Dinner

Unique 1-on-1 meetings

Airport pick-up/drop-off

2-nights at the Hotel Venue

2,800
Exhibition Package
Best Choice

2-Days Summit

Full-Access to all Sessions

3m2 exhibition space

Logo on the conference website

25% discount for extra ticket

Unique 1-on-1 meetings

Cocktail Reception/Gala Dinner

3,550
Event Details
Sponsors